3 Ds - Delirium, dementia, depression Flashcards

1
Q

delirium - features

A

worsening confusion
rapid onset and fluctuant
altered consciousness (alert/aware), disordered thinking
secondary cause

other: emotions, behaviours, hypo/hyperactive, perception changes

hypo 40%, hyper 25%, mixed 35%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

delirium - RF/triggers

A

RF: dementia, frail, age, co-morbidities, sensory impairment

triggers: drugs/substances, infection, surgery, brain disease, hypoxia, metabolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

delirium - assessment approach

A

history and collateral
exam: obs, sepsis, MSK, neuro, sensory, PR
investigations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

delirium - aetiology

A

‘DELIRIUM’: drugs, electrolytes, lack of drugs, infection, reduced senses, intracranial, urinary retention, myocardial

also: trauma, hypoxia, vascular, toxins/heavy metals, sleep, anx/depp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

delirium - prognosis

A
increased mortality (2x; 1y 40%)
longer Ax + institutionalisation
^complications
3x dementia risk (?herald/trigger)
reduced function/incomplete recovery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

delirium - epidemiology

A

20% IP prevalence, 1-2% GP; 50% have dementia (5-10x risk); 67% of dementia IP
AMU 10%, post-op 15%, stroke 25%, HCOP 30%, post-op hip 50%, ITU 60%, palliative 80%

often under-recognised and under-Dx: always consider!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

delirium - management

A

1) ID and treat cause
2) manage Sx: enviro, pain, hydration, nutrition
3) prevent complications: falls, infections, pressure, incontinence, meds, nutrition, fx decline
4) explanations: patient/family

environment: calm, familiar, orientating, big signs
treatment: reassure safety, minimally invasive (no lines), rehydrate, nutrition, bowels, meds, mobility, senses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

delirium - DDx

A

dementia: chronic, general function and IQ
psychiatric: psychosis (e.g. schizophrenia or depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

depression - epidemiology

A

commonest mental disorder in elderly
affects 30% community, 15-20% clinically depressed
1 in 6 don’t discuss Sx with GP
1 in 5 GP attendees have psychological symptoms
1 in 20 are likely to respond to ADD
23% of RH, 30-35% of NH, 29% acute med IP, 40-45% post-stroke
85% also have anxiety
25% of suicides are elderly
10-20% have delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

depression - features

A

more severe baseline illness,
more likely to have psychosis (incl. paranoia), anxiety, and somatisation
more psychosocial impairment (incl. agitation), sleep issues, appetite/weight
increased risk of chronic illness
poorer, slower treatment response
increased suicide risk
pseudo-dementia and delirium DDx; ‘masked depression’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

depression - suicide features

A

more successful: 1in4 success (vs. 1in15-20)
more commonly felt, less commonly expressed
check risk before prescribing ADD
RF: male, bereaved, alone/isolated, pain/physical illness, alcohol, depressed, GP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

depression - management

A

bio: ADD (SSRIs), comorbidities, med r/v
psycho: education + CBT/IAPT
social: usuals; carer support (e.g. respite), diet and exercise, groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

depression - history

A

HPC: onset, Sx, triggers/RF, coping mechs
alcohol/substance
risk/insight; SI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

depression - RF/triggers

A

triggers: life events; health; stress; somatisation
risk factors: PMH/FH; poor physical health, or loss of health/mobility; poverty, or institutionalised; widow/er, alone/isolate, poor social support/no confidant; personality; recent loss/bereavement, retirement; some medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

depression - HCE differences

A
settings: home/OPD/CH/IP
memory/MCI: collaterals
comorbidities + polypharma (MH risk)
perspective: significance and attribution
suicide risk high: more successful

white matter hyperintensity, vascular depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

depression - types

A
mild/moderate/severe +/- psychotic
recurrent depressive
BAD
organic depressive episode
mixed anx/depp
dysthymia
adjustment disorder
minor depressive disorder
17
Q

depression - impact

A

physical health/neglect
QoL/ADL/function
slower recovery
morbidity and mortality

18
Q

dementia - definition/diagnosis

A

“loss of intellectual capacity and personality due to neuron loss/damage, beyond normal ageing”

4 diagnostic criteria:

  • 2 higher function impairments (memory essential)
  • impaired functioning e.g. ADLs
  • no underlying cause (medical or psychiatric) i.e. primary
  • duration > 6 months
19
Q

dementia - stats

A

prevalence: 17-25m worldwide; 850,000 UK (>1m by 2025; 40% increase in next 15y)
33% >95yo; 20% >80yo; 15,000 are younger (~1in20)
F>M (2x)
64% of care home residents

cost: £26b to NHS yearly; family carers save NHS £6b; more than stroke + cancer + CHD; >1% GDP
£11.6b unpaid care, 4.3 health care, 4.5 state social care, 5.8 private social care; other = 0.1b

60,000 deaths per year;
comorbidity: 70% have CMs; 61% anx/depp, 41% lonely, 52% lacking support, 24% feel isolated, 28% lacking capacity/decisions, 90% house-bound
10% delirium

20
Q

dementia - genetics

A

early-onset AD: rare; APP, presenilin 1/2; onset 30-40y; 2x FHX
late-onset AD: apoE4 or apoE3 (more stats)
FTD: MAPP, GRN, TAU

21
Q

dementia - features

A

cortical: memory loss; language; social skills; cognition
subcortical: emotions, movements, memory

personality change
disorientation
loss of higher functions
-memory
-executive function
-visuospatial
-attention and agnosia
-planning and ADLs - dyspraxia and apraxia
-speech - dysphasia
22
Q

dementia - drugs/medications

A

AchE: increase ACH, increase NT; may slow progression; donepezil, galantamine, rivastigmine

NMDA: blocks glutamate, reduces toxic overstimulation and degeneration;

antipsychotics: symptoms

  • psychosocial: behavioural symptoms, emotions (reminiscence, validation, psychotherapy, stimulation/sensory integration), stimulation (e.g. art, pets), cognition
  • future: b-secretase inhibitors, g-secretase inhibitors, a-secretase promotors, anti-aggregants,
  • PD drugs can worsen dementia, APDs can worsen PD esp. halo, chlorpro, sulpiride
23
Q

dementia - DDx

A
MCI: 10-15% develop dementia
delirium
pseudodementia, depression
iatrogenic: med SE
infection
nutrition: B12, B1, B9
metabolic: hypothyroid
SDH and tumours
poison
hydrocephalus
learning difficulties
24
Q

dementia - BPSDs
67-90% at some point
fluctuant

A

psychological: anxiety, depression, insomnia; halls/dels; misID (less common)
behavioural: apathy, aggro, wandering, restless, eating; agitated, pacing, screaming; crying, mannerisms

  • AD: apathy, agitation, anx/depp, irritable
  • VD: apathy, depp, delusions
  • LBD: halls/dels, depp, sleep
  • FTD: apathy, disinhibition, elation, obsession

carer burden, stress, CH/NH, worse functional impairment and mortality

25
Q

dementia - BPSD Mx

A

ID triggers e.g. underlying need
PPH, life events, relationship status, MSE
exclude DDx: delirium, SE, psych

educate and counsel
non-pharma: communication, orientation, familiarity, senses, support, behavioural
pharma: last resort, NOT SEDATIVES; target e.g. sleep, depp, aggro (risperidone), constipation, pain

26
Q

dementia - risks and ethics

A

driving, wandering, fires, falls, neglect, exploitation, abuse

driving/DVLA
disclosure (pros and cons)

27
Q

Alzheimer’s - 62%
500,000 UK
98% cases are >90yo

A

STM first, then personality;
4 As: amnesia, agnosia, aphasia, apraxia
language, recognition, frontal lobes, emotions, senses, balance, ANS (late)

  • phases prominent; variable course; LE 7y from Dx, 14y 3%
  • RF: lipid, HTN, DM, smoking; ?diet/exercise/NSAIDs
28
Q

Vascular dementia - 17%

A
  • M>F; 2nd commonest; types: post-stroke, multi-infarct, small vessel disease, subcortical, mixed (cortical/subcortical)
  • ?preventable: vascular risk factors

-RFs: smoking, alcohol, diet/weight/exercise, HTN, lipids, atherosclerosis, CVD, TIA, DM, age

  • similar to AD, ‘stepwise’ classical but not often present
  • memory, communication, concentration; seizures, incontinence, stroke; depression/lability, behaviour; visual/perceptual;
  • early gait disturbance (unsteady/falls) - ?cerebral hypoperfusion
  • BV damage on imaging (hge, infarcts, ventricular dilation)
29
Q

FTD 2%
more common >65yo
many subtypes e.g. Pick’s

A

insidious, gradual progression
behaviour then cognitive

frontal lobe: personality, emotion, behaviour, hyperphagia, loss of abstract language, disinhibition, primitive reflexes

temporal lobe: language (word finding), echolalia, mutism, perseveration

memory changes later; also hypotension, primitive reflexes, incontinence, akinesia and tremor

3 variants/presentations:

  • behavioural
  • progressive non-fluent aphasia
  • semantic
30
Q

LBD 4%; 25,000 UK

PDD 2%; 30% of PD; 2y PD before dementia

A

similar to AD: memory, attn, communication
interpatient variability

core features:

  • memory;
  • hallucinations (vusual, complex, +/- delusions; 75%);
  • fluctuant attention;
  • parkinsonism (before/after)

associated: syncope/falls, autonomic dysfunction (hypoTN), neuroleptic sensitivity (PD and NMS risk), REM sleep behaviour disorder

31
Q

dementia - assessment

A

history: onset and progression, symptoms, drugs and substances
examination: CVS, neuro (incl. gait and movement), thyroid, liver, MSE, cognitive, co-morbidity (ADLs, GDS, HAP, NPI)

investigations:
bloods: baseline, B12, Ca
ECG + microbiology
neuroimaging (CT 1st line)
?EEG
32
Q

dementia RF

A
smoking and alcohol
atherosclerosis
hypercholesterolaemia: VD and AD
age
genetics
MCI
33
Q

dementia - types

A

aetiology:
degenerative: alzheimer’s, PD/LBD, Huntington’s, FTD, progressive supranuclear palsy
vascular: multi-infarct, cerebral infarcts, CADASIL, vasculitis (e.g. Lupus)
trauma: head injury, boxing, repeated concussions
intracranial malignancy: primary or metastatic
hydrostatic: hydrocephalus
infection: syphilis, HIV, cryptococcus, CJD
toxic/endocrine/metabolic: inherited (Wilson’s), alcohol/drugs, heavy metals, hypothyroid, B12/folate, paraneoplastic
anoxia: cardiac arrest

pathology:
tau: AD, FTD, PSP
synuclein: LBD, PDD
vascular: VD
mixed
secondary: CJD, HD, injury
reversible: vasculitis, infection, metab, vit, hydroceph
environmental: poison, substances, anoxia
34
Q

dementia - pathophysiology

A

general:

  • frontal: personality, reasoning/decisions, inhibition, abstract thought, planning, problem solving, judgement
  • parietal: visuospatial, clumsy, planning, recognition, action sequencing
  • temporal: attention, memory, speech

AD:
-BA plaques (cell apoptosis/lost synapses) and intraneuronal tau tangles (microtubules - communication);
-atrophy (parietal, frontal, cingulate, hippocampus, locus coeruleus);
-large ventricles
VD:
-infarcts, hge, ventricular dilatation
LBD:
-intraneural spherical a-Synuclein protein deposits; prevent NT signalling
-SN: classical (PD); or cortical; DAT scan shows striatal loss (PD vs. ET, LBD vs. AD)
-atrophy: parietal, temporal, cingulate
-loss of ACH neurons in basal nucleus of Meynert
FTD:
-tau proteins; Pick’s = intraneural deposits
-50% inherited

35
Q

dementia - phases

A

early:
- ST memory loss, confusion/disorientation, losing objects
- difficulty with change, an judgment incl. finances
- minor functional behavioural

middle:

  • ADLs
  • people recognition
  • increased forgetfulness
  • disorientation, hallucinations
  • frustration, aggression, self-confidence

late:

  • dependence: incontinence, eating/drinking, frailty, movement/psychomotor
  • speech/language incl. understanding
  • behaviour: aggression, restlessness, distressed, agitation
  • weight loss and dysphagia, malnutrition
36
Q

dementia - management

A

BPS approach
carer support important

medications to improve cognition
medications to relieve symptoms
medications to reduce comorbidity and risk factors

psychosocial:

  • behavioural approach (BPSD)
  • emotion: reminiscence, validation, supportive, therapy, sensory integration, stimulation
  • cognition: orientation, retraining
  • stimulation: art, music, pet, exercise, recreation

support: patient and carer